Cost-effectiveness analysis of lumacaftor and ivacaftor combination for the treatment of patients with cystic fibrosis in the United States

被引：0
作者：
Dolly Sharma
Shan Xing
Yu-Ting Hung
Rachel N. Caskey
Maria L. Dowell
Daniel R. Touchette
机构：
[1] University of Illinois at Chicago,Department of Pharmacy Systems, Outcomes & Policy, College of Pharmacy
[2] University of Illinois at Chicago,Departments of Internal Medicine and Pediatrics
[3] The University of Chicago,Section of Pulmonary and Sleep Medicine, Department of Pediatrics
来源：
Orphanet Journal of Rare Diseases | / 13卷
关键词：
Cost-effectiveness; Cystic fibrosis; Lumacaftor; Ivacaftor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 112 条
  • [61] Whitmore GA(undefined)undefined undefined undefined undefined-undefined
  • [62] Dayton JD(undefined)undefined undefined undefined undefined-undefined
  • [63] Kanter KR(undefined)undefined undefined undefined undefined-undefined
  • [64] Vincent RN(undefined)undefined undefined undefined undefined-undefined
  • [65] Mahle WT(undefined)undefined undefined undefined undefined-undefined
  • [66] Tappenden P(undefined)undefined undefined undefined undefined-undefined
  • [67] Harnan S(undefined)undefined undefined undefined undefined-undefined
  • [68] Uttley L(undefined)undefined undefined undefined undefined-undefined
  • [69] Mildred M(undefined)undefined undefined undefined undefined-undefined
  • [70] Walshaw M(undefined)undefined undefined undefined undefined-undefined
234567891011